DUBLIN--(BUSINESS WIRE)--The "Trypanosomiasis - Global Clinical Trial Pipeline Highlights, 2019" report has been added to ResearchAndMarkets.com's offering. This report provides most up-to-date ...

African sleeping sickness (Human African Trypanosomiasis) is a tropical disease that is endemic in many areas of Sub-Saharan Africa, with a prevalence of around ~60 million people worldwide. In the ...

A herdsman sprays cattle with insecticide to prevent tsetse fly infestation during the Kenya Tsetse and Trypanosomiasis Eradication Council visit to tsetse fly-prone areas in Kina, Isiolo county.

A single dose of oral acoziborole resulted in a greater than 95% cure or probable cure rate for human African trypanosomiasis (HAT), also known as sleeping sickness, according to results from a ...

African trypanosomiasis (also known as sleeping sickness) is a disease transmitted by tsetse flies and is fatal to humans and other animals; however, there is currently no vaccine, this disease is ...

Human African trypanosomiasis (HAT), commonly referred to as sleeping sickness, is a protozoan parasitic infection transmitted by the tsetse fly. Its two causative agents, Trypansoma brucei gambiense ...

A single dose of oral acoziborole proved to be efficacious and safe for adults and adolescents with gambiense human African trypanosomiasis (HAT), also known as "sleeping sickness," suggesting its ...

Multicomponent reactions are protocols that ease the chemical synthesis of new compounds, and are particularly important to gain molecules with biological activity as therapeutic agents against ...

This is a preview. Log in through your library . Abstract Objectives: Human migration and concomitant HIV infections are likely to bring about major changes in the epidemiology of zoonotic parasitic ...